Author:
Haqqani Arsalan S.,Stanimirovic Danica B.
Reference33 articles.
1. Singer BA (2017) The role of natalizumab in the treatment of multiple sclerosis: benefits and risks. Ther Adv Neurol Disord 10:327–336
2. Benucci M, Saviola G, Manfredi M, Sarzi-Puttini P, Atzeni F (2012) Tumor necrosis factors blocking agents: analogies and differences. Acta Biomed 83:72–80
3. Pérot S, Sperandio O, Miteva MA, Camproux A-C, Villoutreix BO (2010) Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery. Drug Discov Today 15:656–667
4. Rossi B, Constantin G (2008) Anti-selectin therapy for the treatment of inflammatory diseases. Inflamm Allergy Drug Targets 7:85–93
5. Engelhardt B, Wolburg H (2004) Mini-review: transendothelial migration of leukocytes: through the front door or around the side of the house? Eur J Immunol 34:2955–2963
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献